InspireMD Inc
XBER:II2

Watchlist Manager
InspireMD Inc Logo
InspireMD Inc
XBER:II2
Watchlist
Price: 5.843 EUR -2.42% Market Closed
Market Cap: 47.2m EUR

Net Margin
InspireMD Inc

-593.5%
Current
-412%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-593.5%
=
Net Income
-46.2m
/
Revenue
7.8m

Net Margin Across Competitors

No Stocks Found

InspireMD Inc
Glance View

Market Cap
47.2m EUR
Industry
Health Care

InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. The firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The company markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. The company is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

II2 Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-593.5%
=
Net Income
-46.2m
/
Revenue
7.8m
What is the Net Margin of InspireMD Inc?

Based on InspireMD Inc's most recent financial statements, the company has Net Margin of -593.5%.

Back to Top